The particular novelty of this study is the use of S. typhimurium to deliver a tumoricidal combination therapy of p53 and Azurin that synergistically induce apoptosis in an intracranial rat model of aggressive GBM tumor in the absence of an adjuvant therapy. Here, TP53 is linked to neoplasm.